Skip to main content
Clinical Trials/IRCT20210828052310N1
IRCT20210828052310N1
Recruiting
Phase 3

Evaluation of the effect of platelet-rich plasma injection in an ovary in cases of poor ovarian function (poor response)

Tehran University of Medical Sciences0 sites12 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
12
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • History of less than 3 eggs per cycle
  • Antimullerian hormone less than 0\.5
  • Antral follicles less than 5
  • Existence of 10 million sperm in sperm analysis
  • At least three percent of normal sperm morphology

Exclusion Criteria

  • Immunological diseases of patients
  • Hematologic disease
  • Chromosomal or genetic disorder
  • Hemoglobin level less than 11 grams per deciliter and platelets less than one hundred and fifty thousand per cubic millimeter
  • Systemic use of corticosteroids within two weeks before the procedure
  • Absence of underlying disease of infertile women
  • No contraindications for pregnancy
  • Uterine disorders
  • Submucosal myoma
  • Asherman syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials